India’s largest private bank spent the weekend without a confirmed CEO for the first time in six years. Sashidhar Jagdishan told HDFC Bank’s board on Saturday that he will not seek reappointment and will retire on October 26, sending the succession race to the top of today’s stocks to watch, alongside a PVR INOX board meeting on a possible buyback and an MSCI India rebalancing that takes effect after today’s close.
Pharma continued to draw regulatory scrutiny, a small-cap wellness stock rallied on a new launch, and a power-infrastructure company posted its highest-ever order book. Here are the stocks to watch today, checked against exchange filings and company disclosures.
Need To Know
- HDFC Bank CEO Sashidhar Jagdishan will retire on October 26, 2026, after declining reappointment; deputy MD Kaizad Bharucha is seen as the leading internal contender, with the RBI’s 15-year whole-time-director cap adding a wrinkle to the timeline.
- PVR INOX‘s board meets today to consider a share buyback, its first since the 2023 PVR-InOX merger—after the multiplex chain turned net cash-positive in Q1 FY27.
- MSCI’s August India review takes effect after today’s close: Adani Energy Solutions, Lenskart, Groww-parent Billionbrains Garage Ventures, and Laurus Labs join the index; Astral, Balkrishna Industries, and SBI Cards exit; Reliance Industries and Jio Financial Services face an estimated $523 million and $61 million in passive outflows from reduced weights.
- Aurobindo Pharma disclosed eight US FDA observations across three facilities in one week; Cipla’s US unit got FDA closure even as its Pithampur (India) plant drew a fresh Form 483.
- Transformers & Rectifiers (India) posted a record ₹6,630-crore order book, up 26% YoY, and separately, Ola Electric’s company secretary Abhishek Jain has resigned.
- Aayush Wellness surged 11.65% on a new Lung Care Tablets launch; Avanti Feeds’ Q1 FY27 profit actually fell 37.4% YoY to ₹116.3 crore, correcting a wrongly-circulated ₹1,163-crore figure.
📊 Track today’s FII/DII cash-market activity live on NiftyTrader’s FII-DII Tracker: niftytrader.in/fii-dii-data
Note: Closing prices below are from Friday, August 28, 2026, the last trading session before today, since markets were shut over the weekend, and are subject to change once trading resumes.
HDFC Bank: The Succession Race Begins
HDFC Bank‘s board took note on Saturday, August 29, that managing director and CEO Sashidhar Jagdishan does not wish to seek reappointment, according to the bank’s BSE filing.
The board said it tried to persuade him to reconsider; he held firm. Jagdishan will retire from the bank’s services at the close of business hours on October 26, 2026, and the board has said it will fast-track the process of finding his successor.
The timing is notable: Jagdishan told Business Standard as recently as March that he was “willing and raring to go” for another term.
Since then, the bank has weathered the resignation of part-time chairman Atanu Chakraborty over governance concerns (later not substantiated by an external legal review), a board reprimand over deposit-pricing practices involving a Maharashtra state agency, and a stock that has fallen roughly 28% from its 52-week high, touching a fresh low of ₹707 on August 28 before paring losses.
Deputy managing director Kaizad Bharucha, the bank’s longest-serving executive board member and a 39-year banking veteran, is emerging as the leading internal contender, alongside chief credit officer Jimmy Tata, according to Reuters and Business Standard reporting. HDFC Bank is also vetting external candidates, as RBI norms require banks to submit multiple names for CEO approval.
One wrinkle: the RBI caps a whole-time director’s tenure, CEO term included, at 15 years. Reuters reports Bharucha wouldn’t hit that mark until 2029, meaning a standard-length term could work within the cap, while a separate Business Standard report published in the early hours of August 31 says a full three-year term for him would still need a specific RBI relaxation. Either way, the bank’s Governance, Nomination, and Remuneration Committee has two months to recommend a name.
Brokerage Macquarie has stayed constructive through the overhang, maintaining an Outperform rating and a ₹1,150 target, arguing the recent weakness reflects leadership uncertainty rather than a deterioration in fundamentals. HDFC Bank’s Q1 FY27 standalone profit was still up mid-single digits YoY with stable asset quality.
MSCI India Rebalance: Reliance, Jio Financial See Outflows As New Names Join
MSCI’s periodic India review, announced August 13 and taking effect after today’s close (for portfolios from September 1), adds four Indian companies to the MSCI India Standard Index and drops three.
Laurus Labs, Lenskart Solutions, Adani Energy Solutions, and Billionbrains Garage Ventures, the parent of broking platform Groww, are the new entrants; Astral, Balkrishna Industries, and SBI Cards and Payment Services exit. That takes the index to 166 constituents from 165 and nudges India’s overall weight in the benchmark up to 11.9% from 11.8%.
Brokerage Nuvama’s flow estimates give a sense of scale: Laurus Labs could see roughly $598 million in passive buying, Lenskart around $352 million, Adani Energy Solutions about $310 million, and Billionbrains Garage Ventures near $256 million.
On the way out, Balkrishna Industries faces an estimated $169 million outflow, SBI Cards about $143 million, and Astral roughly $138 million.
The rebalance isn’t only about additions and exits; index-weight changes matter too. Reliance Industries, still India’s largest listed company, is estimated to see outflows of around $523 million as its weight is trimmed, while Jio Financial Services could see about $61 million move out; Indian Hotels, Aditya Birla Capital, and Colgate-Palmolive India also see reduced weights.
On the flip side, Eternal’s increased weight could draw the single-largest inflow in this cycle at nearly $674 million, with Adani Enterprises (~$202 million), Adani Ports (~$77 million), JSW Energy (~$34 million), Adani Power (~$28 million), GMR Airports (~$22 million), and Swiggy (~$13 million) also in line for incremental buying.
Expect elevated volumes and some price volatility in all of these names in the closing session today, as passive funds tracking the benchmark true up their portfolios.
PVR INOX: Board To Weigh Its First-Ever Buyback
PVR INOX‘s board meets today, August 31, to consider and approve a proposal to buy back the multiplex chain’s equity shares, according to its BSE filing, the company’s first reported buyback consideration since the 2023 PVR-Inox merger. No size, price, or route has been disclosed; the company said it will inform exchanges once the meeting concludes.
The timing follows a turn in the underlying business: PVR INOX posted a consolidated profit after tax of ₹56.5 crore attributable to owners in Q1 FY27 and turned net cash-positive at ₹80.7 crore as of June 30, 2026, after a sustained debt-reduction push.
Two regulatory shifts also make this a live option again: SEBI reopened the stock-exchange buyback route from August 1, 2026, and buyback proceeds have gone back to being taxed as capital gains from April 1, 2026, rather than as dividend income. The trading window for designated persons is closed from August 25 to September 2 ahead of the announcement.
Shares rallied as much as 4.27% to a 52-week high of ₹1,284.50 on August 25 on the news of the board meeting before cooling off to close at ₹1,221.15, down 1.30%, on August 28. The stock is still up roughly 20% over the past month, though it remains down close to 29% over three years.
Aurobindo Pharma: Eight FDA Observations, Three Facilities, One Week
Aurobindo Pharma disclosed three separate USFDA inspection outcomes within the same week in late August. Subsidiary Apitoria Pharma’s Unit-VI in Andhra Pradesh, inspected August 24–28, closed with three observations the company called procedural.
A step-down US subsidiary, Lannett Company LLC, inspected August 17–21 and received four observations.
A third site, AuroPeptides Ltd in Telangana, inspected over the same window and received one observation that the company said relates to facility and equipment maintenance rather than data integrity or GMP compliance. That’s eight observations across three sites in roughly a week, per the company’s exchange filings.
Separately, at its 39th AGM on August 27, shareholders confirmed the ₹4-per-share interim dividend for FY26 that the board had approved back in August 2025 and considered the rotational reappointment of vice-chairman K. Nithyananda Reddy and Dr. M. Madan Mohan Reddy. Shares closed at ₹1,645.30, up 0.51%, on August 28.
Check Live: AUROBINDO PHARMA Options Chart | Nifty Trader
Cipla: One Facility Closes, Another Opens A Fresh Compliance Clock
Two separate Cipla stories are circulating, and they shouldn’t be read as one.
First: the USFDA classified its inspection of InvaGen Pharmaceuticals’ New York facility (inspected July 13–17) as Voluntary Action Indicated on August 28, VAI is the FDA’s formal closure classification for an inspection cycle, so this effectively closes that matter with a single observation on record.
Second, and unrelated: Cipla’s Pithampur (Madhya Pradesh) plant underwent a follow-up cGMP inspection from August 17 to 25 and received a fresh Form 483 with seven observations, which stays open pending the company’s response.
Cipla has also disclosed that its JV, Aspergen Ltd., acquired a 100% stake in Aspergen Inc., USA, as part of a group restructuring. Shares closed at ₹1,423.50, up 0.25%, on August 28.
Also Check: CIPLA Options Chart | Nifty Trader
Ola Electric: S1Z Bookings Open As Company Secretary Steps Down
Ola Electric opened bookings for its S1Z scooter range on August 29, built on its in-house 46-series Bharat Cell LFP battery technology made at its Tamil Nadu gigafactory. The pricing detail worth getting right: the entry 3.1 kWh variant, priced from ₹79,999, carries an IDC-certified range of up to 179 km; it’s the higher 5.1 kWh variant at ₹99,999 that delivers the advertised 301 km.
Separately, Ola Electric secured a ₹95.81-crore incentive under the government’s PLI-Auto scheme for FY27, its third straight year receiving the incentive, after ₹73.74 crore in FY24 and ₹366.78 crore in FY25.
On the governance side, the company has accepted the resignation of company secretary and compliance officer Abhishek Jain, effective the close of business on August 28, as he pursues new opportunities; CFO Deepak Rastogi signed the disclosure.
Jain, who had been in the role since September 2025, is the second senior finance-adjacent departure at the company this year after CFO Harish Abichandani’s exit in January. Shares closed at ₹38.98, up 3.59%, on August 28.
Transformers & Rectifiers (TARIL): Record Order Book, Big Ticket Win
Transformers & Rectifiers (India), widely tracked as TARIL, reported Q1 FY27 revenue of ₹572.34 crore, up 8% YoY, with order inflows surging 218% YoY to ₹2,114 crore.
That took its unexecuted order book to a record ₹6,630 crore as of June 30, 2026, up 26% YoY, against a negotiated enquiry pipeline of roughly ₹23,000 crore. Management is targeting 30% order-inflow growth in FY27 and plans to cut working-capital days from 170 to a 120–130 range.
Separately, the company secured an order in the ₹100–500 crore band from Megha Engineering and Infrastructures Limited (MEIL) for transformer manufacturing, deliverable within 35 months, and is pursuing ₹900–1,000 crore in backward-integration investment, including a proposal to reallocate ₹500 crore of QIP proceeds toward that build-out. Shares closed at ₹303.45, down 0.23%, on August 28.
Advait Energy Transitions: MPPTCL Order Adds To A Growing Backlog
Advait Energy Transitions secured a ₹134.62-crore turnkey order from Madhya Pradesh Power Transmission Company (MPPTCL) on August 25 for Emergency Restoration Systems across 400kV, 220kV and 132 kV lines to be executed within 18 months.
Its outstanding consolidated order book stood at roughly ₹1,330 crore as of June 30, 2026, and on its Q4 FY26 earnings call management guided to a year-end order book of around ₹1,600–1,650 crore by FY27-end. Its new Dholera facility, covering BESS and electrolyser manufacturing, is slated to begin Phase 1 operations in Q4 FY27.
A word of caution on the profit line: reported Q1 FY27 consolidated net profit for Advait varies meaningfully by source, ₹13.89 crore (+65.95% YoY) in some coverage, ₹14.80 crore (+66% YoY, described as including share of profit/loss from associates and JVs) in the company’s own press disclosures, and ₹15.63 crore (+61.2% YoY) in at least one independent analysis.
These likely reflect different profit lines, standalone versus consolidated, with or without JV income, being reported as a single “net profit” figure by different outlets. NiftyTrader is not asserting one number until the exchange-filed results can be reconciled directly. Shares closed at ₹2,200.50, up 4.06%, on August 28.
Aayush Wellness: Lung Care Launch Taps An ₹18,913-Crore Market
Aayush Wellness launched its Lung Care Tablets on August 29, extending its preventive-healthcare portfolio into India’s respiratory healthcare segment, a market that recorded sales of ₹18,912.64 crore in 2025, up roughly 10% from ₹17,199.40 crore in 2024.
The company pointed to India accounting for 30.28% of global deaths from respiratory disease as the underlying opportunity. Shares surged 11.65% to close at ₹27.40 on August 28.
Tata Chemicals: Picking Up Contracts From A Bankrupt US Rival
Tata Chemicals‘ wholly owned US subsidiary, Tata Chemicals North America (TCNA), was declared the successful bidder in the Chapter 11 bankruptcy proceedings of Searles Valley Minerals Inc., acquiring soda ash customer contracts covering more than 500,000 metric tonnes through December 2028 for $21.16 million in cash.
The company expects the contracts to generate upward of $110 million in revenue over that period, per its disclosure. Shares closed at ₹655.75, up 1.80%, on August 28.
Also In Focus Today
More stocks to watch today, in brief:
| Stock | Development | Aug 28 Close | Change |
|---|---|---|---|
| Avanti Feeds | Q1 FY27 consolidated PAT fell 37.4% YoY to ₹116.3 crore (not the ₹1,163-crore figure circulating elsewhere) as feed costs squeezed margins; the board recommended a ₹10/share final FY26 dividend. | ₹826.75 | -2.10% |
| Dr. Agarwal’s Health Care | FY26 PAT up 52.4% YoY to ₹168 crore on ₹2,080-crore revenue; network expanded to 288 facilities after 57 additions, including six in Delhi-NCR. | ₹507.80 | +2.25% |
| Aptech | Q1 FY27 consolidated PAT of ₹7.65 crore, up ~13.6% YoY and ~330% sequentially; disclosed a ₹7.23-crore computer-based examination contract | ₹91.52 | +1.37% |
| Max Estates | Acquired 100% of nine land-owning firms holding 84.71 acres in Najafgarh, West Delhi—its first entry into core Delhi residential—via a ~₹420.2-crore share swap; targeting ₹10,000–12,000 crore GDV | ₹539.05 | -3.47% |
| Ashoka Buildcon | Secured a ₹602.16-crore RVNL order for electro-mechanical works on the Rishikesh–Karnprayag rail line; consolidated order book of ~₹15,251 crore | ₹112.70 | -0.22% |
| Clean Max Enviro Energy Solutions | Board approved a ₹155-crore term sheet with Envision Energy for 1,550 MW of wind turbines; seeking approval for related-party transactions over ₹10,000 crore | ₹1,250.90 | -1.86% |
| Zee Entertainment | SAT granted a one-working-day extension to complete warrant issuance under its ₹3,143-crore preferential allotment to Sunbright Mauritius; the 44th AGM is set for September 17. | ₹101.51 | -2.38% |
| Protean eGov Technologies | Record date of August 28 is fixed for a ₹10/share final FY26 dividend; 31st AGM confirmed for September 22, where the FY27 roadmap around DPI 2.0 and global expansion will be discussed | ₹539.75 | -1.31% |
What This Means For Your Trading Session
Beyond today’s headline stocks to watch, the HDFC Bank succession call is the one with the longest tail: Macquarie’s own base case gives roughly even odds to a short extension versus a full three-year term for whoever gets the nod, and that decision, expected within weeks, not months, is likely to be a bigger swing factor for the stock than any single quarter’s earnings.
A quick, decisive appointment could remove the overhang that’s cost the stock nearly 30%; a prolonged search would likely keep it range-bound.
On the flow side, today’s MSCI implementation and PVR INOX’s buyback verdict both land after the market closes, which means the real price action may show up at tomorrow’s open rather than during today’s session, index funds typically execute MSCI-linked trades in the closing auction. Watch volumes in Reliance Industries, Adani Energy Solutions, and Lenskart particularly closely.
In pharma, the Aurobindo and Cipla disclosures are a reminder that not every FDA observation is created equal; VAI closures and “procedural” observations are routine, while an open Form 483 (like Cipla’s Pithampur one) carries genuine follow-through risk until resolved.
And in the broader power-transmission trade, TARIL’s record order book and Advait’s fresh MPPTCL win both point to the same structural theme: India’s grid-upgrade capex cycle still has legs, even if quarter-to-quarter profit reporting (as Advait’s numbers show) doesn’t always come cleanly.
Read Next: Jio’s Rs 37,700 Crore IPO Aims To Dethrone Hyundai As India’s Biggest Ever
FAQs
Who is likely to become HDFC Bank’s next CEO?
Deputy managing director Kaizad Bharucha, the bank’s longest-serving executive board member, is seen as the leading internal contender alongside chief credit officer Jimmy Tata, though HDFC Bank is also evaluating external candidates as required under RBI norms for CEO appointments at banks.
Why is PVR INOX’s board meeting on a buyback significant?
It would be PVR INOX’s first buyback consideration since the 2023 PVR-Inox merger, coming after the company turned net cash-positive and posted a Q1 FY27 profit, and after SEBI reopened the stock-exchange buyback route and restored capital-gains tax treatment on buybacks.
Which stocks were added to and removed from the MSCI India Index in the August 2026 review?
Laurus Labs, Lenskart Solutions, Adani Energy Solutions and Groww-parent Billionbrains Garage Ventures were added to the MSCI India Standard Index; Astral, Balkrishna Industries and SBI Cards and Payment Services were removed. The changes take effect after trading closes on August 31, 2026.
Should investors worry about the USFDA observations at Aurobindo Pharma and Cipla?
Not uniformly, Aurobindo described most of its observations as procedural, and Cipla’s InvaGen facility actually received an FDA closure (VAI status). Cipla’s Pithampur plant, however, has a fresh, unresolved Form 483 with seven observations that bears watching.
What’s the difference between Ola Electric’s two S1Z scooter variants?
The entry 3.1 kWh variant, priced from ₹79,999, offers an IDC-certified range of up to 179 km; the 301 km range advertised for the S1Z applies only to the higher 5.1 kWh variant, priced at ₹99,999.
This article is for informational purposes only and does not constitute investment advice. NiftyTrader does not recommend buying, selling, or holding any security mentioned. Please consult a SEBI-registered investment advisor before making any investment decisions. Data has been sourced from company filings, stock exchange disclosures, brokerage notes, and other publicly available sources as cited; prices are subject to change once markets open.
